Target Audience

Clinicians, researchers, post-doctoral fellows, medical residents, medical students, and allied health professionals from the region with an interest in current clinical trends and approaches for diagnosis and treatments of Parkinson’s disease.

Goals

  • Facilitate communication between clinicians (including medical specialists, nurses, and allied health professionals) and researchers in the European section of the MDS
  • Disseminate updated knowledge about diagnosis, pathophysiology and management of Parkinson’s disease
  • Improve quality of life and independence of Parkinson’s disease patients and caregivers
  • Promote research and facilitate research collaborations in the field of Parkinson’s disease
  • Expose clinicians and researchers in the European section of the MDS to Parkinson’s disease initiatives and in so doing, encourage their membership in the MDS-ES
     

Learning Objectives

  • Evaluate the mechanisms of degeneration and contribution of genetics in Parkinson patients
  • Apply innovative disease modification strategies in Parkinson’s disease patients through the development of novel therapeutic targets, medications, optimization of dopaminergic drug delivery and neuromodulation techniques
  • Understand the role of new technologies in facilitating remote monitoring and treatment advancement in Parkinson disease
  • Appraise the implications of symptoms to a Parkinson’s disease patient’s quality of life and independence
  • Conduct multidisciplinary team collaborations in disease management in Parkinson’s disease patients


An application has been made to the UEMS EACCME® for CME accreditation of this event.

Top